Showing results (11-20 of 61) with videos related to

Sort By:
Pageof 7
Nederlands Tijdschrift Voor Geneeskunde|June 6, 2019
[Proton pump inhibitors when using clopidogrel: balance between necessity and disadvantages]Kim van der Elst, Berdien Oortgiesen, Willemien Kruik-Kollöffel, et al.
European Journal of Haematology|June 26, 2022
Management of infection prophylaxis in Dutch patients with myelodysplastic syndromes, a web-based case vignette questionnaire: The MINDSET studyJohanne Rozema, Eric van Roon, Lars Vogelzang, et al.
Clinical Therapeutics|June 6, 2017
Microcosting Study of Rituximab Subcutaneous Injection Versus Intravenous InfusionJovan Mihajlović, Pieter Bax, Erwin van Breugel, et al.
Leukemia & Lymphoma|March 11, 2017
Restoration of renal function in patients with newly diagnosed multiple myeloma is not associated with improved survival: a population-based studyJoost C de Vries, Berdien Oortgiesen, Marc H Hemmelder, et al.
Cancers|December 17, 2024
The Evolution of Treatment Policies and Outcomes for Patients Aged 60 and Older with Acute Myeloid Leukemia: A Population-Based Analysis over Two DecadesBenno Diekmann, Nic Veeger, Johanne Rozema, et al.
Transfusion|September 4, 2021
Patterns of transfusion burden in an unselected population of patients with myelodysplastic syndromes: A population-based studyJohanne Rozema, Eric N van Roon, Robby E Kibbelaar, et al.
Blood Transfusion = Trasfusione Del Sangue|December 28, 2020
A clinical effect of disease-modifying treatment on alloimmunisation in transfused patients with myelodysplastic syndromes: data from a population-based studyJohanne Rozema, Christiaan L Slim, Nic J G M Veeger, et al.
British Journal of Haematology|September 12, 2015
Combination therapy with bortezomib, continuous low-dose cyclophosphamide and dexamethasone followed by one year of maintenance treatment for relapsed multiple myeloma patientsEsther G M de Waal, Linda de Munck, Mels Hoogendoorn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 22, 2005
Primary allogeneic T-cell responses against mantle cell lymphoma antigen-presenting cells for adoptive immunotherapy after stem cell transplantationMels Hoogendoorn, Judith Olde Wolbers, Willem M Smit, et al.
Expert Review of Anticancer Therapy|August 25, 2021
Cost-effectiveness of lenalidomide plus rituximab versus rituximab monotherapy in patients with previously treated follicular lymphoma: a societal viewFrederick W Thielen, Marie-José Kersten, Pim Kuizenga, et al.
Pageof 7